Two advisory panels to the Food and Drug Administration on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by
Tumor Necrosis Factor-alpha (TNFá) Blockers: Label Change – Boxed Warning Updated for Risk of Infection from Legionella and Listeria
AUDIENCE: Rheumatology, Gastroenterology, Oncology ISSUE: FDA notified healthcare professionals that the Boxed Warning for the entire class of Tumor Necrosis Factor-alpha (TNFá) blockers has been
Miscarriage risk doubles with use of anti-inflammatory drugs
Common anti-inflammatory drugs such as ibuprofen and naproxen may increase the chance of miscarriage if they are taken early in pregnancy, a new study suggests.
Bad batteries in defibrillators tied to cardiac deaths
When Ralph Polanec collapsed June 25 at his Washington, D.C., gym, staff members thought they could save him with a shock from their automated external
FDA May Classify Surgical Mesh Devices for Failing Organs as High Risk
Johnson & Johnson, Boston Scientific Corp. (BSX) and other makers of surgical mesh may have to submit added safety data to regulators to keep their
